Skip to main content
Livermore
Livermore
ZHEN

UBS Group AG

SEC CIK
0001610520
Latest filing
Aug 13, 2026

ORIC holding history

Oric Pharmaceuticals, Inc. in every 13F filed by UBS Group AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ORIC overviewAll 13F holders of ORICFull Q2 2026 holdings

Shares (Q2 2026)
222,923
Value
$2.41M
% of portfolio
<0.1%
Quarters held
20
Since Q1 2021
Holdings of ORIC by UBS Group AG, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026222,923$2.41M<0.1%+28,234+14.5%AddedHolders
Q1 2026194,689$2.47M<0.1%−540,169−73.5%ReducedHolders
Q4 2025734,858$6.01M<0.1%+395,622+116.6%AddedHolders
Q3 2025339,236$4.07M<0.1%+240,230+242.6%AddedHolders
Q2 202599,006$1.00M<0.1%+19,468+24.5%AddedHolders
Q1 202579,538$443.8K<0.1%+4,609+6.2%AddedHolders
Q4 202474,929$604.7K<0.1%+3,374+4.7%AddedHolders
Q3 202471,555$733.4K<0.1%−9,252−11.4%ReducedHolders
Q2 202480,807$571.3K<0.1%−13,254−14.1%ReducedHolders
Q1 202494,061$1.29M<0.1%+53,088+129.6%AddedHolders
Q4 202340,973$377.0K<0.1%+23,701+137.2%AddedHolders
Q3 202317,272$104.5K<0.1%−4,996−22.4%ReducedHolders
Q2 202322,268$172.8K<0.1%+22,268NewHolders
Q1 20230$00.0%−4,433−100.0%Sold outHolders
Q4 20224,433$26.1K<0.1%+4,300+3,233.1%AddedHolders
Q3 2022133$00.0%−2,071−94.0%ReducedHolders
Q2 20222,204$10.0K<0.1%+2,204NewHolders
Q1 20220$00.0%−62,399−100.0%Sold outHolders
Q4 202162,399$917.0K<0.1%+36,413+140.1%AddedHolders
Q3 202125,986$544.0K<0.1%+18,747+259.0%AddedHolders
Q2 20217,239$128.0K<0.1%−24,265−77.0%ReducedHolders
Q1 202131,504$772.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.